Agreement includes Actinium-225 (Ac-225) and Lutetium-177 (Lu-177) to support Ariceum’s therapeutic programsWEST...
Nusano and Ariceum Therapeutics Announce Multi-Isotope Supply Agreement
read more
News
Nusano Announces September 2025 Conference Schedule
WEST VALLEY CITY, Utah – Sept. 4, 2025 – Nusano, a leader in advanced isotope and energy technologies, today announced...
Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility
Pictured (L-R): Howard Lewin, Nusano co-founder & Chief Product Development Officer; Glenn Rosenthal, Nusano...
Nusano Establishes Strategic Advisory Board to Support Innovation Across Company’s Product Verticals
The Honorable Dr. David J. Shulkin, Corey Johnston and Seema Singh Bhan Appointed as Initial Advisory Board...
Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
Pairing of custom-built klystrons and fast-pulse modulators enable production of up 12 radioisotopes in a single run...
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
The following is a copy of a press release issued by Cellectar BiosciencesPartnership Provides Long-Term Supply of...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates